A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Making the Energy Efficiency Case to the C-Suite
How to Avoid HAIs This Flu Season
Design Phase Set to Begin for Hospital Annex at SUNY Upstate Medical
Building Hospital Resilience in an Era of Extreme Weather
Ennoble Care Falls Victim to Data Breach